CIK 0001630113 · Non-accelerated filer<br>Smaller reporting company
BIOTRICITY INC.
Sign in to watch- Ticker
- BTCY
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 472548273
- Phone
- (800) 590-4155
- Business address
- 203 REDWOOD PARKWAY, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- METASOLUTIONS, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-12 | Rosa David A Director | Grant or award · Option (right to buy) | +75,930 | 474,683 | ||
| 2023-03-12 | Al-Siddiq Waqaas President, CEO and Chairman | Grant or award · Option (right to purchase) | +350,000 | 3,549,984 | ||
| 2023-03-12 | Al-Siddiq Waqaas President, CEO and Chairman | Grant or award · Option (right to purchase) | +350,000 | 3,899,984 | ||
| 2023-03-12 | Al-Siddiq Waqaas President, CEO and Chairman | Grant or award · Option (right to purchase) | +1,000,000 | 4,899,984 | ||
| 2022-12-31 | Ayanoglou John Chief Financial Officer | Grant or award · Warrants | +218,785 | 1,328,488 | ||
| 2022-09-30 | Ayanoglou John Chief Financial Officer | Grant or award · Warrants | +118,282 | 1,109,703 | ||
| 2022-06-30 | Ayanoglou John Chief Financial Officer | Grant or award · Warrants | +53,827 | 991,421 | ||
| 2022-03-31 | Ayanoglou John Chief Financial Officer | Grant or award · Warrants | +37,594 | 937,594 | ||
| 2021-12-31 | Ayanoglou John Chief Financial Officer | Grant or award · Warrants | +50,000 | 900,000 | ||
| 2021-11-29 | Betts Norman M. Director | Grant or award | +54,348 | 375,598 | ||
| 2021-11-29 | Rosa David A Director | Grant or award | +27,174 | 152,174 | ||
| 2021-10-11 | Rosa David A Director | Sale | −3,318 | $3.05 | $10K | 125,000 |
| 2021-10-08 | Rosa David A Director | Sale | −9,481 | $3.20 | $30K | 128,318 |
| 2021-10-07 | Rosa David A Director | Sale | −17,228 | $3.08 | $53K | 137,799 |
| 2021-09-30 | Ayanoglou John Chief Financial Officer | Grant or award · Warrants | +50,000 | 850,000 | ||
| 2021-09-16 | Rosa David A Director | Sale | −34,977 | $3.43 | $120K | 155,027 |
| 2021-09-15 | Rosa David A Director | Sale | −6,246 | $3.27 | $20K | 190,004 |
| 2021-06-30 | Ayanoglou John Chief Financial Officer | Grant or award · Warrants | +50,000 | 800,000 | ||
| 2021-03-31 | Ayanoglou John Chief Financial Officer | Grant or award · Warrants | +50,000 | 750,000 | ||
| 2021-03-21 | Rosa David A Director | Grant or award · Option (right to buy) | +31,106 | 398,753 |
Page 1 of 2 · 39 trades